Differential migratory properties of mouse, fish, and frog leukocytes treated with agonists of opioid receptors

Developmental and Comparative Immunology

Volumn 28, Issue 9, 2004, Pages 949-958

  Chadzinska, Magdalena ^a   Plytycz, Barbara ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Carassius auratus; Chemotaxis; Inflammation; Leukocytes; Migration; Opioids; Rana esculenta

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DELTORPHIN; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALTRINDOLE; OPIATE AGONIST; OPIATE RECEPTOR; ZYMOSAN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; FISH; FROG; INHIBITION KINETICS; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

AMPHIBIA; ANURA; CARASSIUS AURATUS; RANA ESCULENTA;

EID: 2942525779     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2004.02.003     Document Type: Article

References (27)

1. Ader R., Cohen N., Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet. 345:1995;99-103
2. Adler M.W., Geller E.B., Rogers T.J., Henderson E.E., Eisenstein T.K. Opioids, receptors, and immunity. Adv Exp Med Biol. 335:1993;13-20
3. Stefano G.B., Scharrer B., Smith E.M., Hughes T.K. Jr, Magazine H.I., Bilfinger T.V., Hartman A.R., Fricchione G.L., Liu Y., Makman M.H. Opioid and opiate immunoregulatory processes. Crit Rev Immunol. 16:1996;109-144
4. Peterson P.K., Molitor T.W., Chao C.C. Mechanisms of morphine-induced immunomodulation. Biochem Pharmacol. 46:1993;343-348
5. Cherny N.I. Opioid analgesics: comparative features and prescribing guidelines. Drugs. 51:1996;713-737
6. Plytycz B., Natorska J. Morphine attenuates pain and prevents inflammation in experimental peritonitis. Trends Immunol. 23:2002;345-346
7. Chadzinska M., Kolaczkowska E., Seljelid R., Plytycz B. Morphine modulation of peritoneal inflammation in Atlantic salmon and CB6 mice. J Leukoc Biol. 65:1999;590-596
8. Chadzinska M., Jozefowski S., Bigaj J., Plytycz B. Morphine modulation of thioglycollate-elicited peritoneal inflammation in the goldfish, Carassius auratus. Arch Immunol Ther Exp (Warsz). 45:1997;321-327
9. Chadzinska M., Scislowska-Czarnecka A., Plytycz B. Inhibitory effects of morphine on some inflammation-related parameters in the goldfish Carassius auratus L. Fish Shellfish Immunol. 10:2000;531-542
10. Kolaczkowska E., Menaszek E., Seljelid R., Plytycz B. Experimental peritonitis in anuran amphibians is not suppressed by morphine treatment. Pol J Pharmacol. 52:2000;323-326
11. Kolaczkowska E., Shahzidi S., Seljelid R., van Rooijen N., Plytycz B. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation. 26:2002;61-71
12. Kolaczkowska E. Experimental acute peritonitis and its modulation by morphine: involvement of mast cells and macrophages. PhD Thesis, University of Tromso, Norway; 2001.
13. Singhal P.C., Kapasi A.A., Franki N., Reddy K. Morphine-induced macrophage apoptosis: the role of transforming growth factor-beta. Immunology. 100:2000;57-62
14. Grimm M.C., Ben-Baruch A., Taub D.D., Howard O.M., Resau J.H., Wang J.M., Ali H., Richardson R., Snyderman R., Oppenheim J.J. Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. J Exp Med. 188:1998;317-325
15. Grimm M.C., Ben-Baruch A., Taub D.D., Howard O.M., Wang J.M., Oppenheim J.J. Opiate inhibition of chemokine-induced chemotaxis. Ann NY Acad Sci. 840:1998;9-20
16. Choi Y., Chuang L.F., Lam K.M., Kung H.F., Wang J.M., Osburn B.I., Chuang R.Y. Inhibition of chemokine-induced chemotaxis of monkey leukocytes by mu-opioid receptor agonists. In vivo. 13:1999;389-396
17. Rogers T.J., Steele A.D., Howard O.M., Oppenheim J.J. Bidirectional heterologous desensitization of opioid and chemokine receptors. Ann NY Acad Sci. 917:2000;19-28
18. Chadzinska M., Przezdzienk U., Plytycz B. Morphine enhances chemokinesis of fish, amphibian, and mammalian leukocytes. Central-Eur J Immunol. 24:1999;218-223
19. Rainard P., Sarradin P., Paape M.J., Poutrel B. Quantification of C5a/C5a(desArg) in bovine plasma, serum and milk. Vet Res. 29:1998;73-88
20. Smith L.C., Clow L.A., Terwilliger D.P. The ancestral complement system in sea urchins. Immunol Rev. 180:2001;16-33
21. Chao C.C., Hu S., Shark K.B., Sheng W.S., Gekker G., Peterson P.K. Activation of mu opioid receptors inhibits microglial cell chemotaxis. J Pharmacol Exp Ther. 281:1997;998-1004
22. Negri L., Melchiorri P., Lattanzi R. Pharmacology of amphibian opiate peptides. Peptides. 21:2000;1639-1647
23. Lazarus L.H., Bryant S.D., Attila M., Salvadori S. Frog skin opioid peptides: a case for environmental mimicry. Environ Health Perspect. 102:1994;648-654
24. Amiche M., Delfour A., Nicolas P. Opioid peptides from frog skin. Jolles P. D-amino acids in sequences of secreted peptides of multicellular organisms. 1998;57-71 Birkhauser Verlag, Basel/Switzerland
25. Newman L.C., Sands S.S., Wallace D.R., Stevens C.W. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates. J Pharmacol Exp Therap. 301:2002;364-370
26. Stefano G.B., Salzet B., Fricchione G.L. Enkelytin and opioid peptide association in invertebrates and vertebrates: immune activation and pain. Immunol Today. 19:1998;265-268
27. Józefowski S., PLytycz B. Characterization of opiate binding sites on the goldfish (Carassius auratus L.) pronephric leukocytes. Pol J Pharmacol. 49:1997;229-237